13F-HR filed by StepStone Group LP
StepStone Group LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 22 holding rows worth $555,592,526.
- Accession
- 0000950123-24-001852
- Filer
- CIK 1502287
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 22 entries on the cover page, a total value of $555,592,526 stated on the cover page (in dollars after the unit check, H1), rows summing to $555,592,526 with VALUE read as dollars as filed, 13F file number 028-15126. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DUN & BRADSTREET HLDGS INC | 26484T106 | COM | 21,239,288 | $248,499,670 | dollars as filed | |
| WALKME LTD ORD SHS | M97628107 | Stock | 10,366,855 | $110,614,343 | dollars as filed | |
| MONEYLION INC | 60938K304 | CL A | 779,050 | $48,838,645 | dollars as filed | |
| ROCKET LAB USA INC | 773122106 | COM | 8,206,916 | $45,384,245 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 1,357,840 | $33,728,746 | dollars as filed | |
| ROBLOX CORP CL A | 771049103 | Stock | 578,563 | $26,451,901 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 826,569 | $13,266,433 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 761,277 | $11,487,670 | dollars as filed | |
| NEUEHEALTH INC | 10920V404 | COM NEW | 525,252 | $4,007,658 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 422,085 | $3,853,636 | dollars as filed | |
| DOMA HOLDINGS INC | 25703A203 | COM | 595,180 | $2,755,683 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 462,163 | $1,497,408 | dollars as filed | |
| KANZHUN LIMITED | 48553T106 | SPONSORED ADS | 86,189 | $1,431,599 | dollars as filed | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 1,573,357 | $1,351,514 | dollars as filed | |
| VACASA INC | 91854V107 | COM | 147,261 | $1,197,232 | dollars as filed | |
| GROVE COLLABORATIVE HOLDINGS | 39957D201 | Common Stock | 380,383 | $673,278 | dollars as filed | |
| Uber Technologies | 90353T100 | COM | 2,718 | $167,347 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 4,568 | $134,847 | dollars as filed | |
| Couchbase Inc | 22207T101 | Common Stock | 5,918 | $133,274 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 10,241 | $61,241 | dollars as filed | |
| QUANTUMSCAPE CORP COM CL A | 74767V109 | Stock | 8,079 | $56,149 | dollars as filed | |
| AMYRIS INC | 03236M200 | COM NEW | 2,816 | $7 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-001852 | this filing | 2024-02-13 | acceptance time not in the bulk data set |